Search Results - Gilliland, D. Gary

Refine Results
  1. 1
    Myeloproliferative disorders

    Myeloproliferative disorders by Levine, Ross L., Gilliland, D. Gary

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    EGFR Inhibition in Non-Small Cell Lung Cancer: Resistance, Once Again, Rears Its Ugly Head

    EGFR Inhibition in Non-Small Cell Lung Cancer: Resistance, Once Again, Rears Its Ugly Head by Clark, Jennifer, Cools, Jan, Gilliland, D. Gary

    Published 2005
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    The leukemic stem cell niche: current concepts and therapeutic opportunities

    The leukemic stem cell niche: current concepts and therapeutic opportunities by Lane, Steven W., Scadden, David T., Gilliland, D. Gary

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Isolation of Early Hematopoietic Stem Cells from Murine Yolk Sac and AGM

    Isolation of Early Hematopoietic Stem Cells from Murine Yolk Sac and AGM by Morgan, Kelly, Kharas, Michael, Dzierzak, Elaine, Gilliland, D. Gary

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    A progenitor cell origin of myeloid malignancies

    A progenitor cell origin of myeloid malignancies by Haeno, Hiroshi, Levine, Ross L., Gilliland, D. Gary, Michor, Franziska

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Socs-1 Inhibits TEL-JAK2-Mediated Transformation of Hematopoietic Cells through Inhibition of JAK2 Kinase Activity and Induction of Proteasome-Mediated Degradation

    Socs-1 Inhibits TEL-JAK2-Mediated Transformation of Hematopoietic Cells through Inhibition of JAK2 Kinase Activity and Induction of Proteasome-Mediated Degradation by Frantsve, Julie, Schwaller, Juerg, Sternberg, David W., Kutok, Jeffery, Gilliland, D. Gary

    Published 2001
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Uniform sensitivity of FLT3 activation loop mutants to the tyrosine kinase inhibitor midostaurin

    Uniform sensitivity of FLT3 activation loop mutants to the tyrosine kinase inhibitor midostaurin by Barry, Elly V., Clark, Jennifer J., Cools, Jan, Roesel, Johannes, Gilliland, D. Gary

    Published 2007
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    The TEL/platelet-derived growth factor β receptor (PDGFβR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-dependent signaling pathways

    The TEL/platelet-derived growth factor β receptor (PDGFβR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-depe... by Carroll, Martin, Tomasson, Michael H., Barker, George F., Golub, Todd R., Gilliland, D. Gary

    Published 1996
    Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Expression of Jak2V617F causes a polycythemia vera–like disease with associated myelofibrosis in a murine bone marrow transplant model

    Expression of Jak2V617F causes a polycythemia vera–like disease with associated myelofibrosis in a murine bone marrow transplant model by Wernig, Gerlinde, Mercher, Thomas, Okabe, Rachel, Levine, Ross L., Lee, Benjamin H., Gilliland, D. Gary

    Published 2006
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Systematic Genomic Screen for Tyrosine Kinase Mutations in CLL

    Systematic Genomic Screen for Tyrosine Kinase Mutations in CLL by Brown, Jennifer R, Levine, Ross L., Thompson, Christina, Basile, Gabrielle, Gilliland, D Gary, Freedman, Arnold S

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation

    Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation by Lu, Xiaohui, Levine, Ross, Tong, Wei, Wernig, Gerlinde, Pikman, Yana, Zarnegar, Sara, Gilliland, D. Gary, Lodish, Harvey

    Published 2005
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Signal transduction and transforming properties of the TEL–TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia

    Signal transduction and transforming properties of the TEL–TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia by Liu, Qing, Schwaller, Juerg, Kutok, Jeffery, Cain, Danielle, Aster, Jon C., Williams, Ifor R., Gilliland, D.Gary

    Published 2000
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412

    Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412 by Growney, Joseph D., Clark, Jennifer J., Adelsperger, Jennifer, Stone, Richard, Fabbro, Doriano, Griffin, James D., Gilliland, D. Gary

    Published 2005
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    X-inactivation–based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis

    X-inactivation–based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a sub... by Levine, Ross L., Belisle, Claude, Wadleigh, Martha, Zahrieh, David, Lee, Stephanie, Chagnon, Pierre, Gilliland, D. Gary, Busque, Lambert

    Published 2006
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Roles of tyrosine 589 and 591 in STAT5 activation and transformation mediated by FLT3-ITD

    Roles of tyrosine 589 and 591 in STAT5 activation and transformation mediated by FLT3-ITD by Rocnik, Jennifer L., Okabe, Rachel, Yu, Jin-Chen, Lee, Benjamin H., Giese, Neill, Schenkein, David P., Gilliland, D. Gary

    Published 2006
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice

    Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice by Kharas, Michael G., Okabe, Rachel, Ganis, Jared J., Gozo, Maricel, Khandan, Tulasi, Paktinat, Mahnaz, Gilliland, D. Gary, Gritsman, Kira

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Constitutively activated FGFR3 mutants signal through PLCγ-dependent and -independent pathways for hematopoietic transformation

    Constitutively activated FGFR3 mutants signal through PLCγ-dependent and -independent pathways for hematopoietic transformation by Chen, Jing, Williams, Ifor R., Lee, Benjamin H., Duclos, Nicole, Huntly, Brian J. P., Donoghue, Daniel J., Gilliland, D. Gary

    Published 2005
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Ott1 (Rbm15) Is Essential for Placental Vascular Branching Morphogenesis and Embryonic Development of the Heart and Spleen

    Ott1 (Rbm15) Is Essential for Placental Vascular Branching Morphogenesis and Embryonic Development of the Heart and Spleen by Raffel, Glen D., Chu, Gerald C., Jesneck, Jonathan L., Cullen, Dana E., Bronson, Roderick T., Bernard, Olivier A., Gilliland, D. Gary

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Ott1(Rbm15) has pleiotropic roles in hematopoietic development

    Ott1(Rbm15) has pleiotropic roles in hematopoietic development by Raffel, Glen D., Mercher, Thomas, Shigematsu, Hirokazu, Williams, Ifor R., Cullen, Dana E., Akashi, Koichi, Bernard, Olivier A., Gilliland, D. Gary

    Published 2007
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletion

    mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletion by Lee, Jae Y., Nakada, Daisuke, Yilmaz, Omer H., Tothova, Zuzana, Joseph, Nancy M., Lim, Megan S., Gilliland, D. Gary, Morrison, Sean J.

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: